This post has expired! It was posted more than 90 days ago.
<- Back

91399 - Personalising prostate cancer care - Current treatment options

  • : Online


Online learning module with an original peer-reviewed update on current treatment options for managing prostate cancer

Relevance to General Practice

- Treatment for men with prostate cancer can now be tailored according to patient, tumour, imaging and genetic factors. 
- Many patients with low-risk Gleason 6 prostate cancer (International Society of Urological Pathology [ISUP] grade group 1) do not require treatment and can instead be safely monitored. Criteria for offering 
active surveillance rather than definitive treatment to men has been updated. 
- Active surveillance may allow up to 50% of patients to avoid unnecessary treatment. 
- Studies have found that 10 to 30% of patients (10% of modern well-assessed patients) on active surveillance programs required treatment over a 15-year period, because of either disease progression or patient preference.8

Learning outcomes

  • Identify men with prostate cancer who are suitable for active surveillance
  • Participate in active surveillance of men with prostate cancer
  • Discuss with patients treatment options for prostate cancer and their side effects
  • Take steps to make men more comfortable during intimate examinations
91399 - Personalising prostate cancer care - Current treatment options
1 hour
Start Date
End Date
CPD Points
1 hour
Contact Phone
Log in into view this field.